R E Hempling - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R E Hempling

Showing results (51-60 of 55) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 55 results.

Cancer|April 1, 1993

A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinomaP G Rose, M S Piver, J H Malfetano, et al.

Gynecologic Oncology|February 18, 1999

Characterization of human ovarian carcinomas in a SCID mouse modelY Xu, D F Silver, N P Yang, et al.

Journal of Surgical Oncology|September 1, 1993

Predictive value of serum CA125 following optimal cytoreductive surgery during weekly cisplatin induction therapy for advanced ovarian cancerR E Hempling, M S Piver, N Natarajan, et al.

International Journal of Radiation Oncology, Biology, Physics|July 15, 1993

Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterusM L Hicks, M S Piver, J L Puretz, et al.

Gynecologic Oncology|October 29, 1998

Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancerG H Eltabbakh, M S Piver, R E Hempling, et al.

Pageof 6

Search research articles

Showing results (51-60 of 55) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 55 results.

Cancer|April 1, 1993

A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinomaP G Rose, M S Piver, J H Malfetano, et al.

Gynecologic Oncology|February 18, 1999

Characterization of human ovarian carcinomas in a SCID mouse modelY Xu, D F Silver, N P Yang, et al.

Journal of Surgical Oncology|September 1, 1993

Predictive value of serum CA125 following optimal cytoreductive surgery during weekly cisplatin induction therapy for advanced ovarian cancerR E Hempling, M S Piver, N Natarajan, et al.

International Journal of Radiation Oncology, Biology, Physics|July 15, 1993

Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterusM L Hicks, M S Piver, J L Puretz, et al.

Gynecologic Oncology|October 29, 1998

Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancerG H Eltabbakh, M S Piver, R E Hempling, et al.

Pageof 6